ResearcherEstuarine and Coastal Studies FoundationActive in the last 2 years
Sounetra Choudhury
Matched on OpenAlex author ID A5121263072. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 3
- Decrypting the impact of ferroptosis and cuproptosis in development of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.compbiolchem.2025.108867↗
- Identification of a chromatin-modifying gene-histone lysine N-methyl transferase (KMT2C/MLL3) as a potential immunomodulator oncogene in Indian pancreatic canc… Co-author DOI 10.1186/s40001-025-03661-6↗
- Oncometabolites in pancreatic cancer: Strategies and its implications. Co-author DOI 10.5493/wjem.v14.i4.96005↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Arunima Maiti · 3 shared papers, 2024–2026 · strength 0.81
- Paper Decrypting the impact of ferroptosis and cuproptosis in development of pancreatic ductal adenocarcinoma. DOI 10.1016/j.compbiolchem.2025.108867↗
- Paper Oncometabolites in pancreatic cancer: Strategies and its implications. DOI 10.5493/wjem.v14.i4.96005↗
- Paper Identification of a chromatin-modifying gene-histone lysine N-methyl transferase (KMT2C/MLL3) as a potential immunomodu… DOI 10.1186/s40001-025-03661-6↗
- Nilabja Sikdar · 3 shared papers, 2024–2026 · strength 0.81
- Paper Decrypting the impact of ferroptosis and cuproptosis in development of pancreatic ductal adenocarcinoma. DOI 10.1016/j.compbiolchem.2025.108867↗
- Paper Oncometabolites in pancreatic cancer: Strategies and its implications. DOI 10.5493/wjem.v14.i4.96005↗
- Paper Identification of a chromatin-modifying gene-histone lysine N-methyl transferase (KMT2C/MLL3) as a potential immunomodu… DOI 10.1186/s40001-025-03661-6↗
- Deepyaman Das · 1 shared paper, 2026 · strength 0.33
- Akash Bararia · 1 shared paper, 2025 · strength 0.22
- Sudeep Banerjee · 1 shared paper, 2025 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.